Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

HTGM
HTG Molecular Diagnostics, Inc. Common Stock
stock NASDAQ

Inactive
Jun 14, 2023
0.4800USD-20.000%(-0.1200)773,040
Pre-market
0.00USD-100.000%(-0.60)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 28, 2022
08:00AM EST  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors.   GlobeNewswire Inc
Jan 7, 2022
01:07PM EST  Craig-Hallum Upgrades HTG Molecular Diagnostics to Buy, Raises Price Target to $8   Benzinga
Jan 6, 2022
08:13AM EST  HTG Molecular Diagnostics Sees Prelim. FY21 sales $8.9M vs $8.84M Est.   Benzinga
08:00AM EST  HTG Molecular Diagnostics Announces Certain Preliminary   GlobeNewswire Inc
Dec 22, 2021
04:07PM EST  HTG Completes HTP Product Next-Phase Development Milestone   Benzinga
Dec 16, 2021
04:05PM EST  HTG Expands Therapeutics Scientific Advisory Board With Addition   GlobeNewswire Inc
Dec 9, 2021
09:46PM EST  HTG Molecular Diagnostics Announces That It Has Exceeded $1M Of Revenue Recognized From Sales Of Its HTG Transcriptome Panel   Benzinga
08:00AM EST  HTG Announces Major Sales Milestone for HTG Transcriptome Panel   GlobeNewswire Inc
Nov 17, 2021
08:06AM EST  HTG And Icahn School Of Medicine At Mount Sinai Announce Bladder Cancer Research Collaboration; Financial Details Not Disclosed   Benzinga
08:00AM EST  HTG and Icahn School of Medicine at Mount Sinai Announce Bladder   GlobeNewswire Inc
Nov 15, 2021
08:00AM EST  HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under   GlobeNewswire Inc
Nov 10, 2021
05:42PM EST  HTG Molecular Diagnostics Q3 EPS $(0.60) Beats $(0.66) Estimate, Sales $2.50M Miss $2.65M Estimate   Benzinga
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 9, 2021
12:07PM EST  Preview: HTG Molecular Diagnostics's Earnings   Benzinga
Nov 2, 2021
04:05PM EDT  HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial   GlobeNewswire Inc
Oct 5, 2021
08:00AM EDT  HTG Expands Therapeutics Team   GlobeNewswire Inc
Sep 30, 2021
11:19AM EDT  HTG Molecular Diagnostics's Return On Capital Employed Insights   Benzinga
Sep 21, 2021
08:00AM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will present in a fireside chat in Cantor Fitzgeralds Virtual Global Healthcare Conference, being held September 27th 30th, 2021.   GlobeNewswire Inc
Sep 8, 2021
04:10PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwrights 23rd Annual Global Investment Conference, being held September 13th 15th, 2021.   GlobeNewswire Inc
Aug 12, 2021
04:23PM EDT  HTG Molecular Diagnostics Q2 EPS $(0.39) Beats $(0.77) Estimate, Sales $2.10M Miss $2.13M Estimate   Benzinga
04:05PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2021.   GlobeNewswire Inc
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 5, 2021
08:38AM EDT  HTG's New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe   Benzinga
Aug 3, 2021
08:00AM EDT  HTG Molecular Diagnostics to Announce Second Quarter 2021   GlobeNewswire Inc
Jul 23, 2021
08:00AM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that, on July 13th and July 22nd, 2021 the Compensation Committee of the HTG Board of Directors granted inducement stock option awards to purchase an aggregate of 30,000 shares of common stock to two employees who have recently joined HTG.   GlobeNewswire Inc
Jul 20, 2021
08:06AM EDT  HTG Forms New Drug Discovery Business Unit   Benzinga
Jun 30, 2021
09:29AM EDT  HTG Molecular Diagnostic 13G Filing From Hewlett Fund Shows 5.64% Stake In Co.   Benzinga
Jun 22, 2021
10:53AM EDT  HTG Receives First Order For HTG Transcriptome Panel, Enters Two European EAP Agreements   Benzinga
08:04AM EDT  HTG Molecular Diagnostics Receives First Commercial Orders For Planned HTG Transcriptome Panel, Signs 2 European Early Adopter Program Deals, No Terms Disclosed   Benzinga
08:00AM EDT  HTG Receives First Commercial Orders for its Planned HTG   GlobeNewswire Inc
Jun 14, 2021
08:07AM EDT  HTG Says Completes Product Design Lock For Planned Transcriptome Panel, Announces Signing Of 3 Early Adopter Program Collaboration Agreements   Benzinga
08:00AM EDT  HTG Completes Product Design Lock for its Planned Transcriptome   GlobeNewswire Inc
Jun 7, 2021
06:25AM EDT  AIGH Capital Management, LLC Discloses 9.8% Passive Stake In HTG Molecular   Benzinga
May 24, 2021
04:12PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its HTG EdgeSeq technology is highlighted in several posters being presented at the American Society of Clinical Oncology (ASCO) conference, being held virtually from June 4-8, 2021.   GlobeNewswire Inc
May 18, 2021
07:44AM EDT  The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO   Benzinga
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
07:50AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
06:43AM EDT  SVB Leerink Maintains Outperform on HTG Molecular Diagnostics, Lowers Price Target to $10   Benzinga
06:29AM EDT  HC Wainwright & Co. Maintains Buy on HTG Molecular Diagnostics, Lowers Price Target to $9   Benzinga
May 13, 2021
04:34PM EDT  Recap: HTG Molecular Diagnostics Q1 Earnings   Benzinga
04:32PM EDT  HTG Molecular Diagnostics Q1 EPS $(0.80) Beats $(1.02) Estimate, Sales $1.44M Miss $1.69M Estimate   Benzinga
04:05PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31, 2021.   GlobeNewswire Inc
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
03:07PM EDT  HTG Molecular Diagnostics Granted Canadian Patent Titled 'METHODS OF DETECTING GENE FUSIONS USING FIRST AND SECOND NUCLEIC ACID PROBES'   Benzinga
May 4, 2021
04:01PM EDT  HTG Molecular Diagnostics to Announce Q1 2021 Financial Results   GlobeNewswire Inc
10:32AM EDT  'We are excited to announce that we are attending #ASCO 2021. If you're attending, we hope you will stop by our virtual exhibit and check out our free downloads' -Tweet From HTG Molecular   Benzinga
Apr 6, 2021
08:05AM EDT  The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout   Benzinga
Apr 5, 2021
04:04PM EDT  HTG Molecular Sees Q1 Sales ~$1.4M vs $2.4M Estimate   Benzinga
04:03PM EDT  HTG Molecular Sees FY21 Sales Up 30-40% Year Over Year   Benzinga
04:03PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain preliminary financial results for the first quarter ended March 31, 2021.   GlobeNewswire Inc
Mar 26, 2021
06:26AM EDT  HC Wainwright & Co. Maintains Buy on HTG Molecular Diagnostics, Lowers Price Target to $11   Benzinga
Mar 25, 2021
04:03PM EDT  HTG Molecular Diagnostics FY20 EPS $(4.51) vs $(7.60 In FY19, Sales $8.55M vs $19.2M in FY19   Benzinga
04:01PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the year ended December 31, 2020.   GlobeNewswire Inc
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
04:03AM EDT  Earnings Scheduled For March 25, 2021   Benzinga
Mar 16, 2021
04:01PM EDT  HTG Molecular Diagnostics to Announce Year End 2020 Financial   GlobeNewswire Inc
Feb 26, 2021
08:00AM EST  HTG Concludes Feasibility Testing & Releases Second White Paper   GlobeNewswire Inc
Feb 23, 2021
09:33AM EST  HTG Molecular Tweets 'We're excited to share a publication that used a multi-omics approach and cited the Rotterdam Study that used the #HTGEdgeSeq miRNA Whole Transcriptome Assay to help identify miRNAs associated with #cardiometabolic risk factors...'   Benzinga
Jan 19, 2021
04:10PM EST  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that Timothy (TJ) B. Johnson has resigned his positions as Executive Chairman and a member of HTGs Board of Directors. Ann F. Hanham, Ph.D. will remain as Lead Independent Director.   GlobeNewswire Inc
Jan 5, 2021
08:06AM EST  HTG Molecular Diagnostics Sees FY 2020 Revs. ~$8.5M   Benzinga
08:00AM EST  HTG Molecular Diagnostics Announces Certain Preliminary 2020   GlobeNewswire Inc
Dec 30, 2020
08:07AM EST  HTG Extends Patent Portfolio With New Canadian Patent For Nuclease Protection Methods For Detection Of Nucleotides Variants   Benzinga
08:00AM EST  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has received notification of the issuance of Canadian patent number 2877729 for Nuclease Protection Methods for Detection of Nucleotide Variants.   GlobeNewswire Inc
Dec 18, 2020
08:03AM EST  HTG Announces First Collaborator In Early Access Program For iIs Prototype Whole Transcriptome Panel   Benzinga
08:00AM EST  HTG Announces First Collaborator in Early Access Program for its   GlobeNewswire Inc
Dec 8, 2020
04:14PM EST  HTG Announces An Early Access Program For Its Prototype Whole Transcriptome Panel   Benzinga
04:01PM EST  HTG Announces an Early Access Program for its Prototype Whole   GlobeNewswire Inc
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 23, 2020
08:10AM EST  HTG Announces 1-for-15 Reverse Split Effective 11/20/2020   Benzinga
08:00AM EST  HTG Announces One-for-Fifteen Reverse Stock Split   GlobeNewswire Inc
Nov 11, 2020
04:15AM EST  SVB Leerink Maintains Outperform on HTG Molecular Diagnostics, Lowers Price Target to $1   Benzinga
Nov 10, 2020
04:30PM EST  HTG Molecular Diagnostics: Q3 Earnings Insights   Benzinga
04:05PM EST  HTG Molecular Diagnostics Q3 EPS $(0.07) Beats $(0.08) Estimate, Sales $1.78M Miss $2.23M Estimate   Benzinga
04:01PM EST  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended September 30, 2020.   GlobeNewswire Inc
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
10:20AM EST  Earnings Preview for HTG Molecular Diagnostics   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Nov 2, 2020
04:07PM EST  HTG Demonstrates Technical Feasibility For A Whole Transcriptome Panel Using HTG EdgeSeq Technology   Benzinga
04:01PM EST  HTG Demonstrates Technical Feasibility for a Whole Transcriptome   GlobeNewswire Inc
Oct 30, 2020
08:00AM EDT  HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial   GlobeNewswire Inc
Sep 8, 2020
04:01PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced JohnLubniewski, President and CEO of HTG, will present virtually at the H.C. Wainwright 22ndAnnual Global Investment Conference and at the Cantor Fitzgerald Global Healthcare Conference. Details are as follows:   GlobeNewswire Inc
Aug 18, 2020
08:05AM EDT  HTG Introduces Oncology Applications, Expands Analytics Capabilities With Release Of New Software Update   Benzinga
08:00AM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commercial release and immediate availability of HTG EdgeSeq Reveal version 3.0, adding additional applications and software functionalities.   GlobeNewswire Inc
Aug 14, 2020
02:22PM EDT  HTG Molecular Provides Update On Patent Infringement Claims Against BioSpyder   Benzinga
02:17PM EDT  HTG Molecular Provides Update on Patent Infringement Claims   GlobeNewswire Inc
Aug 11, 2020
06:19PM EDT  HTG Molecular Diagnostics: Q2 Earnings Insights   Benzinga
04:05PM EDT  HTG Molecular Diagnostics Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $2.00M Beat $1.79M Estimate   Benzinga
04:01PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2020.   GlobeNewswire Inc
04:02AM EDT  Earnings Scheduled For August 11, 2020   Benzinga
Aug 10, 2020
04:16PM EDT  HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN   Benzinga
04:01PM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of a Commercialization and Distribution Agreement (Master Agreement) with QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (QIAGEN).   GlobeNewswire Inc
11:15AM EDT  Earnings Preview: HTG Molecular Diagnostics   Benzinga
Aug 5, 2020
04:01PM EDT  HTG Molecular Diagnostics to Announce Second Quarter 2020   GlobeNewswire Inc
Aug 4, 2020
08:32AM EDT  HTG Molecular Diagnostics Announces Pre-Launch Introduction Of HTG EdgeSeq Reveal RUO Oncology Applications   Benzinga
08:00AM EDT  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Reveal RUO oncology applications, which are expected to be commercially available globally in late August with the release of HTG EdgeSeq Reveal version 3.0.   GlobeNewswire Inc
Jul 28, 2020
04:25PM EDT  HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel   Benzinga
Jul 23, 2020
04:05PM EDT  HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC